Clinical Trial Update: Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PT007 to placebo MDI and open-label Proventil in adults and adolescents with asthma has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PT007
• Proventil-HFA (albuterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-07-24